価格表

在庫・価格 : 2025年09月11日 18時50分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-OCT3/4, Rabbit-Poly
データシート
GTX101497 GNTジーンテックス
GeneTex International Corporation
25 μl ¥30,000
(未発注)
追加

在庫・価格 : 2025年09月11日 18時50分 現在

Anti-OCT3/4, Rabbit-Poly

  • 商品コード:GTX101497
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥30,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Deng H et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice. Cell Transplant ;29:963689720927392
Deng H et al
PubMed
2 Assoun EN et al. Characterization of iPS87, a prostate cancer stem cell-like cell line. Oncotarget 2020 Mar;11(12):1075-1084
Assoun EN et al
2020/01/01
PubMed
3 Wang YY et al. Visfatin Enhances Breast Cancer Progression through CXCL1 Induction in Tumor-Associated Macrophages. Cancers (Basel) 2020 Nov;12(12)
Wang YY et al
2020/01/01
PubMed
4 Fang W et al. Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation. Biomark Med 2020 10;14(15):1473-1484
Fang W et al
2020/01/01
PubMed
5 Chiou HC et al. Stemness regulation of the adrenal mixed corticomedullary tumorigenesis-a case-control study. Neoplasia 2020 07;22(7):263-271
Chiou HC et al
2020/01/01
PubMed
6 Brown RM et al. Human Cytomegalovirus Compromises Development of Cerebral Organoids. J Virol 2019 09;93(17)
Brown RM et al
2019/01/01
PubMed
7 Chen YK et al. Sphere-forming-like cells (squamospheres) with cancer stem-like cell traits from VX2 rabbit buccal squamous cell carcinoma. Int J Oral Sci 2014 Dec;6(4):212-8
Chen YK et al
2014/01/01
PubMed
8 He Q et al. Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation. Stem Cell Res Ther 2021 08;12(1):449
He Q et al
2021/01/01
PubMed
9 Zhang W et al. Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system. Stem Cell Res 2021 Nov;57:102611
Zhang W et al
2021/01/01
PubMed
10 Salti A et al. High Glycolytic Activity Enhances Stem Cell Reprogramming of Fahd1-KO Mouse Embryonic Fibroblasts. Cells 2021 Aug;10(8)
Salti A et al
2021/01/01
PubMed
11 Peng F et al. Oncogenic AURKA-enhanced N<sup>6</sup>-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. Cell Res 2021 Mar;31(3):345-361
Peng F et al
2021/01/01
PubMed
12 Ye P et al. Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells. Biomolecules 2022 May;12(5)
Ye P et al
2022/01/01
PubMed
13 H旦pperger S et al. Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C&#xA0;&gt;&#xA0;T (p.Q105*) in the COL3A1 gene. S
H旦pperger S et al
2024/01/01
PubMed
14 J Liu et al., Knockdown of TRIP13 inhibits gastric cancer stemness and cisplatin resistance by regulating FBXW7/ENO1 axis, Trop J Pharm Res., 2024., 23(1)., 27-35

PubMed
15 Tsai YF et al. RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma. Cancer Cell Int 2023 Oct;23(1):231
Tsai YF et al
2023/01/01
PubMed
16 Wang CH et al. Cbx7 promotes the generation of induced pluripotent stem cells. Regen Ther 2023 Dec;24:443-450
Wang CH et al
2023/01/01
PubMed
17 CH Wang et al., Cbx7 promotes the generation of induced pluripotent stem cells., Regen Ther., 2023., 24., 443-450

PubMed
18 Cardile A et al. Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers. Antioxidants (Basel) 2023 Jun;12(7)
Cardile A et al
2023/01/01
PubMed
19 Mohankumar K et al. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells. Mol Carcinog 2022 Jan;61(1):73-84
Mohankumar K et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Deng H et al. Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice. Cell Transplant ;29:963689720927392
    Deng H et al
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Assoun EN et al. Characterization of iPS87, a prostate cancer stem cell-like cell line. Oncotarget 2020 Mar;11(12):1075-1084
    Assoun EN et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wang YY et al. Visfatin Enhances Breast Cancer Progression through CXCL1 Induction in Tumor-Associated Macrophages. Cancers (Basel) 2020 Nov;12(12)
    Wang YY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fang W et al. Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation. Biomark Med 2020 10;14(15):1473-1484
    Fang W et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Chiou HC et al. Stemness regulation of the adrenal mixed corticomedullary tumorigenesis-a case-control study. Neoplasia 2020 07;22(7):263-271
    Chiou HC et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Brown RM et al. Human Cytomegalovirus Compromises Development of Cerebral Organoids. J Virol 2019 09;93(17)
    Brown RM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chen YK et al. Sphere-forming-like cells (squamospheres) with cancer stem-like cell traits from VX2 rabbit buccal squamous cell carcinoma. Int J Oral Sci 2014 Dec;6(4):212-8
    Chen YK et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    He Q et al. Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic &#x3B2;-cell dedifferentiation. Stem Cell Res Ther 2021 08;12(1):449
    He Q et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Zhang W et al. Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system. Stem Cell Res 2021 Nov;57:102611
    Zhang W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Salti A et al. High Glycolytic Activity Enhances Stem Cell Reprogramming of Fahd1-KO Mouse Embryonic Fibroblasts. Cells 2021 Aug;10(8)
    Salti A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Peng F et al. Oncogenic AURKA-enhanced N<sup>6</sup>-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. Cell Res 2021 Mar;31(3):345-361
    Peng F et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ye P et al. Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells. Biomolecules 2022 May;12(5)
    Ye P et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    H旦pperger S et al. Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C&#xA0;&gt;&#xA0;T (p.Q105*) in the COL3A1 gene. S
    H旦pperger S et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    J Liu et al., Knockdown of TRIP13 inhibits gastric cancer stemness and cisplatin resistance by regulating FBXW7/ENO1 axis, Trop J Pharm Res., 2024., 23(1)., 27-35

  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Tsai YF et al. RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma. Cancer Cell Int 2023 Oct;23(1):231
    Tsai YF et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Wang CH et al. Cbx7 promotes the generation of induced pluripotent stem cells. Regen Ther 2023 Dec;24:443-450
    Wang CH et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    CH Wang et al., Cbx7 promotes the generation of induced pluripotent stem cells., Regen Ther., 2023., 24., 443-450

  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Cardile A et al. Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers. Antioxidants (Basel) 2023 Jun;12(7)
    Cardile A et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Mohankumar K et al. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells. Mol Carcinog 2022 Jan;61(1):73-84
    Mohankumar K et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed